Tirzepatide
Tirzepatide is a dual agonist that activates both the GIP and GLP-1 receptors. Like semaglutide it has a long half-life and is dosed weekly. The dual mechanism is a key difference from GLP-1-only agonists.
Educational reference only. TrackPep is a tracking and organization tool, not medical advice. Consult a qualified healthcare professional for health decisions.